Analysis of Cellular Health Screening Market Size by Research Nester Reveals the Market to Grow with a CAGR of ~10% During 2024-2036 and Attain ~USD 93 Billion by 2036

Research Nester’s recent market research analysis on “Cellular Health Screening Market: Global Demand Analysis & Opportunity Outlook 2036” delivers a detailed competitors analysis and a detailed overview of the global cellular health screening market in terms of market segmentation by type, sample, collection site, and by region.

Growing Awareness about Preventive Health Measures During Covid-19 Pandemic Time to Promote Global Market Share of Cellular Health Screening

The global cellular health screening market is estimated to grow majorly on account of the increase in the global population's awareness of preventive health measures during a pandemic. The most frequent tests carried out over the previous 12 months, according to the NCBI article published in June 2022, were blood pressure readings (83%), blood sugar testing (66.2%), urinalysis (53.1%), and liquid panel tests (55.1%). The market growth is likely to be stimulated by a large number of preventive health checks in the Pandemic period. In addition, due to a growing preference for preventive care which will contribute to the growth of the market over the next few years, demand for cellular health checks is expected to remain constant during the post-pandemic period.  This growing awareness about preventive care is further driving the growth of the cellular health screening market in the estimated time period.

Some of the major growth factors and challenges that are associated with the growth of the global cellular health screening market are:

Growth Drivers:

• Surge in Advanced Technologies
• Rising Need for Personalized Medicines

Challenges:

The cellular health screening test can be expensive, especially for multi-test panels. Cellular health screening tests often require specialized equipment and reagents that can be expensive to purchase and maintain. This coat is further predicted to affect the market growth negatively. This can be a barrier to access for some patients particularly those without insurance. Therefore, this high cost of cellular health screening is anticipated to hamper the market growth. Besides this, data security concerns associated with and lack of standardization are some of the major factors anticipated to hamper the global market size of cellular health screening.

By sample, the global cellular health screening market is segmented into blood, urine, serum, and saliva. The urine segment is to garner a notable revenue by the end of 2036 by growing at a significant CAGR over the forecast period. The urine sample process is patient-friendly, takes less time as it doesn’t involve any technical procedure in it and they are also non-invasive. In addition, urine screening has been shown to be successful in assessing oxidative stress. For example, Japanese researchers have shown that the presence of pteridine derivatives in urine has an association with Oxidative Stress and Cigarette Smoking in their research article which appeared in July 2020. Its widespread usage in the detection and treatment of a variety of illnesses, including renal ailments, UTI infections, and diabetes, can also be attributed to the increase. Additionally, patients can do the simple and non-invasive procedure of collecting their own urine without the use of a technician or piece of equipment. Additionally, a urine sample is utilized to identify heavy metals, measure oxidative stress, and examine cell health.

By region, the Europe cellular health screening market is to generate notable revenue by the end of 2036. This growth is anticipated by the growing prevalence of chronic diseases along with the growing integration of advanced technologies and preventive & effective treatments of numerous diseases. This is predicted to boost the market growth in the Europe region during the projected period. Besides, growing technological advancement in cellular health screening in the Europe region. Escalating technological advancements are making cellular health screening more accurate, affordable, and accessible. For instance, new blood tests can now measure a wide range of cellular health markers, and direct-to-consumer cellular health screening kits are becoming increasingly popular. Therefore, increasing technological advancement in cellular health screening is driving the market expansion of cellular health screening in the upcoming time period.  

This report also provides the existing competitive scenario of some of the key players of the global cellular health screening market which includes company profiling of Quest Diagnostics, Bio-Reference Laboratories Inc., QIAGEN NV, Bloom Diagnostics,           Cell Science System Corporation, Laboratory Corporation of American Holdings,